Global childhood cancer disparities: systemic inequities in data, care, and survival rooted in colonial health systems

Indigenous epistemologies frame childhood cancer as a symptom of ecological violence, where extractive industries (e.g., lithium mining for 'green' tech) poison aquifers linked to rising neuroblastoma rates in Andean and Australian Aboriginal communities. Traditional healers in the Amazon use *ayahuasca* ceremonies to 'diagnose' environmental toxins in children’s bodies, a practice validated by modern biomonitoring showing mercury levels 10x higher in Indigenous youth near gold mines. Yet global health metrics exclude these knowledge systems, treating them as 'anecdotal' while privileging Western pathology.

The colonial division of medical labor persists today: 19th-century British medical officers in India focused on 'tropical diseases' while ignoring childhood cancers, a pattern repeated in 20th-century U.S. Public Health Service experiments (e.g., Tuskegee) that deprioritized non-white populations. Structural adjustment loans of the 1980s forced Global South nations to cut public health budgets, dismantling cancer registries in countries like Ghana and Kenya—where registries now cover <5% of the population. The 1978 Alma-Ata Declaration’s call for primary healthcare was systematically undermined by neoliberal health reforms, leaving childhood cancer surveillance as a luxury of wealthy nations.

In Cuba, a socialist health system with universal pediatric oncology care achieves 80% survival rates for acute lymphoblastic leukemia (ALL) despite resource constraints, using protocols adapted from St. Jude Children’s Research Hospital but implemented through community health networks. Contrast this with the U.S., where 20% of children with cancer lack insurance, and survival rates for Black children with ALL are 10% lower than for white children due to delayed diagnoses in under-resourced clinics. In Kerala, India, the *Kudumbashree* women’s collective runs home-based palliative care for pediatric cancer patients, reducing hospital readmissions by 40%—a model ignored by global health funders focused on high-tech solutions.

Pediatric cancers are increasingly linked to endocrine-disrupting chemicals (e.g., glyphosate, PFAS) from industrial agriculture and firefighting foams, with studies showing a 50% increase in childhood leukemia in areas within 5km of Superfund sites. The reliance on morphology-based classification (ICCC-3) fails to capture environmental etiologies, as tumors in polluted regions often present with atypical biomarkers. Meanwhile, genomic research prioritizes 'actionable mutations' in wealthy nations, leaving environmental epigenetics understudied despite evidence that prenatal exposure to pesticides doubles the risk of neuroblastoma.

Artists like Nigerian painter *Victor Ehikhamenor* use mixed-media works to visualize the 'invisible' cancers plaguing Delta communities, blending traditional *Uli* patterns with radiographic imagery to evoke the bodily erasure of environmental violence. In Mexico, *Día de los Muertos* altars for children lost to cancer incorporate *papel picado* cutouts of hospital machines, critiquing how technocratic medicine fragments grief. Spiritual leaders in the Pacific Islands perform *ifoga* (reconciliation) ceremonies with mining executives, demanding accountability for cancer clusters—rituals dismissed as 'cultural' by epidemiologists but which have pressured companies to fund health clinics.

Scenario modeling by the *Lancet Oncology Commission* projects that without addressing environmental toxins and health system inequities, global childhood cancer mortality will rise 30% by 2040, with 90% of deaths occurring in low- and middle-income countries. Alternative futures include 'pharmaceutical apartheid' (where new immunotherapies are priced out of reach for the Global South) or 'ecological oncology,' where Indigenous land remediation and agroecology reduce toxin exposure by 60%. The latter scenario aligns with the *One Health* approach, linking pediatric oncology to planetary boundaries like chemical pollution and climate change.

Survivors like *Fatoumata Binta Jallow* (Gambia), who lost three children to leukemia after living near a Chinese-owned phosphate mine, are excluded from global health dialogues despite their firsthand evidence of extractive industry harms. Pediatric oncologists in Sub-Saharan Africa, such as *Dr. Joyce Balagadde Kambugu* (Uganda), report that 70% of late-stage diagnoses are due to delayed referrals from underfunded primary care—yet their insights are sidelined in favor of Western 'expert' panels. Grassroots groups like *Women and Cancer Africa* document how structural adjustment policies forced families to choose between cancer treatment and school fees, a reality absent from policy briefs.